Wells Fargo lowered the firm’s price target on Westlake (WLK) to $95 from $110 and keeps an Overweight rating on the shares. The firm is lowering its estimates for Westlake but remains bullish given its ability to generate nearly MSD quarter-over-quarter volume growth in HIP despite an unfavorable macro backdrop, and on potential near-term pricing tailwinds within PEM.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Resilient Growth and Strategic Positioning: Westlake Chemical’s Buy Rating Amidst Macroeconomic Challenges
- Westlake price target lowered to $117 from $132 at Truist
- Westlake price target lowered to $100 from $135 at Barclays
- Westlake Corporation Faces Challenges in Q1 2025
- Westlake Chemical’s Earnings Call: Mixed Results Amid Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue